Skip to main content
Clinical Trials/EUCTR2008-001940-38-IT
EUCTR2008-001940-38-ITActive, not recruitingNot Applicable

Functional RMN study to evaluate the prompt and middle term effect of the treatment with Donepezil in patients affected by multiple sclerosis and mild impairment of cognitive function. - ND

OSPEDALE S. RAFFAELE0 sitesStarted: April 14, 2008Last updated:
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • patients affected by relapsing and remittent SM primarily progressive with a mild cognitive impairment, defined by a score minor than cut off at at least 1 memory test and/or on execution and attention, or to 2 tests related to the same functions; age between 18 and 65; patients able to give their informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • Not provided

Investigators

Sponsor
OSPEDALE S. RAFFAELE

Similar Trials